Roche deals API plants in SC, CO

Roche Carolina has returned money given by the state of South Carolina to keep open its 300,000-square-foot facility in Florence. The drugmaker announced late last year that it might close the plant. But it was apparently swayed by a $500,000 state incentive and said in June that it would keep the plant open for "at least a few more years," according to SCnow.com.

But Roche returned the money late last week, and officials hope the funds can be used elsewhere (or by Florence itself in the future). The plant, which employs about 300, manufactures the active ingredients for Tamiflu and Xeloda, a chemotherapy drug. 

The FDA listed Tamiflu for oral suspension in short supply last month and in January.

And in Boulder, CO, last week, International Chemical Investors Group said it plans to acquire Roche Colorado, which includes a pharma production facility. Some 265 development and manufacturing personnel staff the site, which Roche bought in 1994.

ICIG will operate the site as part of its Corden Pharma unit.

Under terms of the transaction, Corden will supply Roche with APIs currently made at the facility. It aims to meet the drugmaker's demand for "commercial scale peptides and other medicinal compounds," according to the Boulder County Business Report. The workforce is expected to remain intact.

- see the SC story
- here's the Boulder story

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)